UAE Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By City, Opportunities and Forecast, 2017-2031F

UAE generic drugs market is projected to witness a CAGR of 7.72% during the forecast period 2024-2031, growing from USD 3 billion in 2023 to USD 5.43 billion in 2031. The growth of the market is supported by the rising cases of chronic diseases, the expansion of the geriatric population, and growing awareness about the benefits of generic drugs among the general population.

The country is witnessing increasing demand for generic drugs due to improvements in healthcare services and the implementation of visionary plans and investments by the government to strengthen the growth of the healthcare sector.

The rising emphasis on technological advancements, population health, and the growth of Middle Eastern pharmaceutical distributors also supports the UAE generic drugs market growth. The government is also making efforts to reduce the cost of healthcare in the UAE by promoting the adoption of generic drugs. Furthermore, the rising prevalence of chronic diseases and disorders is also propelling the demand for generic drugs in the UAE. According to estimates from the International Diabetes Federation (IDF), the prevalence of diabetes in the adult population of the country is 12.3%. For treating such conditions that are lifelong and require frequent medications, patients often prefer generic versions due to their economic nature.

Expansion of the Geriatric Population

The rapid growth of the geriatric population is boosting the UAE generic drugs market growth. According to estimates from the United Nations Population Fund, the number of individuals aged sixty and above is projected to increase from approximately 311,000 to 2 million between 2020-2050. This increase is propelling the requirement for generic drugs as the older population is more susceptible to various diseases and disorders, and the availability of generic drugs offers them access to effective and safe therapeutic solutions, which are also cost-efficient. The older population also has a different set of healthcare requirements and often require assistance and homecare and self-management services. In such situations the availability of economically viable therapeutics releases them of additional financial burdens.

Growing Awareness Boosts Market Expansion

The rising awareness about the quality and safety of generic drugs in the country is propelling the expansion of the market. The government has taken various measures to educate the population about the production process of generics in order to eliminate any notion about the ineffectiveness of those drugs due to their cost-efficient nature. Generic drugs cost less than their brand-name counterparts as they are not required to repeat the studies and clinical trials to showcase their effectiveness and safety. However, they do adhere to the same quality standards as those of branded drugs. They undergo the same quality testing processes as the others and have the same active pharmaceutical ingredient (API) present as the non-generic drug. As the awareness and understanding of the production process of generics increases in the country, so does their demand, which in turn provides lucrative growth opportunities to the market.

Cardiovascular Segment Holds Significant Market Share

The rising cases of cardiovascular diseases in the country are boosting the segment’s expansion. Cardiovascular diseases are one of the most common non-communicable diseases across the globe. As per the estimates of the World Health Organization (WHO), they account for approximately 40% of all the deaths related to non-communicable diseases in the country. These diseases involve blood vessels and the heart and include coronary heart disease, cerebrovascular disease, congenital heart disease, pulmonary embolism, deep vein thrombosis, rheumatic heart disease, and peripheral arterial disease. The rising cases of cardiovascular diseases can be attributed to a lack of physical activity and an unhealthy diet, among others. The growing adoption of inactive lifestyles and increasing consumption of fast food are thus propelling the cases of cardiovascular diseases in the country, which in turn is boosting the demand for generic drugs.

Download Free Sample Report

Retail Pharmacies Hold a Major Share of the Market

The growth of the retail pharmacy chains in the country is increasing the accessibility of generic drugs. In July 2024, Life Healthcare Group announced the launch of their four hundredth outlet in the country. The largest pharmacy chain in the UAE is known for providing a comprehensive range of pharmaceuticals, vitamins, minerals, supplements, lifestyle, wellness, and beauty products. Over the past 27 years, the group has been dedicated to increasing the affordability and accessibility of therapeutics and healthcare solutions in the country. Additionally, the growth of the segment can also be attributed to the convenience and personalized touch offered by retail pharmacies. Furthermore, the retail pharmacies in the country are also actively investing in the adoption of new technologies and solutions to become more patient-centric. In November 2023, Burjeel Pharmacy announced the transformation of their pharmacies and made customers experience the focal point of their stores. They are focusing on improving customer experience by ensuring hassle-free and easy access shopping experience.

Future Market Scenario (2024-2031F)

As per the UAE generic drugs market analysis, the growth of the market is expected to be supported by increasing initiatives by the government to promote healthcare sustainability and affordability. The reliance on generic drugs is also expected to increase due to the increasing prevalence of chronic diseases in the country.

In the country’s economic diversification plans, healthcare and life sciences are expected to play a significant role. The Abu Dhabi Economic Vision 2030 aims to develop a skilled and productive workforce and develop a resilient structure that has the potential to support the expected economic growth. The increasing emphasis on minimizing reliance on imported pharmaceuticals and improving the healthcare infrastructure is also expected to boost the demand for generic drugs in the UAE market.

Report Scope

“UAE Generic Drugs Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of UAE generic drugs market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031
Projected Growth Rate	CAGR of 7.72% between 2024 and 2031
Revenue Forecast in 2031	USD 5.43 billion
Segments Covered	Application, Type, Brand, Route of Administration, Distribution Channel
Cities Covered	Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al-Quwain, Fujairah, Ras Al Khaimah
Key Companies Profile	Neopharma, Sun Pharma Global FZE, Gulf Pharmaceutical Industries (Julphar), Tabuk Pharmaceuticals, Pharmax Pharmaceuticals FZ LLC, Novartis Pharma Services AG, Lupin Middle East FZ-LLC, Axantia Holding
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, UAE generic drugs market has been segmented into the following categories: 

• By Application
  • Neurovascular
  • Cardiovascular
  • Dermatology
  • Oncology
  • Diabetology
  • Respiratory
  • Others
• By Type
  • Biosimilar Generics
  • Small Molecule Generics
• By Brand
  • Branded Generic
  • Pure Generic
• By Route of Administration
  • Oral
  • Injectable
  • Topical
  • Others
• By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• By City
  • Abu Dhabi
  • Dubai
  • Sharjah
  • Ajman
  • Umm Al-Quwain
  • Fujairah
  • Ras Al Khaimah

Key Players Landscape and Outlook

The increase in investments towards specialty pharmaceutical companies in the country is boosting the UAE generic drugs market size. In March 2024, Mubadala Investment Company PJSC, a state-owned global investment management company, reached a definitive agreement for purchasing KELIX Bio Limited, which is focused on providing complex generic drugs in emerging economies. The main goal of the acquisition is to strengthen the development of UAE’s life science ecosystem, contributing to the diversification of its economy and establishing it as a global leader in the life science sector. This acquisition is also expected to enhance the country’s reputation in the field of life sciences.

Key Players Operating in UAE Generic Drugs Market are:

• Neopharma
• Sun Pharma Global FZE
• Gulf Pharmaceutical Industries (Julphar)
• Tabuk Pharmaceuticals
• Pharmax Pharmaceuticals FZ LLC
• Novartis Pharma Services AG
• Lupin Middle East FZ-LLC
• Axantia Holding

Markets and Data’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for UAE generic drugs market, you may approach our team at info@marketsandata.com.